down arrow

United Therapeutics Corp.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US91307C1027
USD
484.10
9.96 (2.1%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,877.40
2,327.50
1,936.30
1,685.50
1,483.30
1,448.80
1,627.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,877.40
2,327.50
1,936.30
1,685.50
1,483.30
1,448.80
1,627.80
Raw Material Cost
309.70
257.50
151.60
122.50
108.10
117.60
198.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
42.90
59.30
32.40
18.60
23.50
44.20
13.90
Selling and Distribution Expenses
709.70
473.50
470.90
464.50
423.90
336.20
260.40
Other Expenses
43.81
34.87
29.05
39.14
32.88
32.96
34.40
Total Expenditure (Excl Depreciation)
1,500.40
1,139.00
945.40
997.00
884.30
827.60
817.00
Operating Profit (PBDIT) excl Other Income
1377
1188.5
990.9000000000001
688.5
599
621.1999999999999
810.8
Other Income
204.90
148.70
5.00
58.90
54.30
45.40
20.90
Operating Profit (PBDIT)
1,654.40
1,390.40
1,047.20
797.30
703.20
712.50
867.60
Interest
42.90
59.30
32.40
18.60
23.50
44.20
13.90
Exceptional Items
0.00
-3.60
-12.90
-134.90
9.10
-787.40
-58.90
Gross Profit (PBDT)
2,567.70
2,070.00
1,784.70
1,563.00
1,375.20
1,331.20
1,429.10
Depreciation
72.50
53.20
51.30
49.90
49.90
45.90
35.90
Profit Before Tax
1,539.00
1,274.30
950.60
593.90
638.90
-165.00
758.90
Tax
343.90
289.50
223.30
118.10
124.10
-60.50
169.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,195.10
984.80
727.30
475.80
514.80
-104.50
589.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,195.10
984.80
727.30
475.80
514.80
-104.50
589.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,195.10
984.80
727.30
475.80
514.80
-104.50
589.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
6,444.00
5,984.80
4,796.70
3,958.90
3,395.20
2,780.40
2,788.60
Earnings per share (EPS)
24.64
19.81
15.0
10.06
11.54
-2.39
13.39
Diluted Earnings per share
24.64
19.81
15.0
10.06
11.54
-2.39
13.39
Operating Profit Margin (Excl OI)
47.86%
51.06%
51.17%
40.85%
40.38%
42.88%
49.81%
Gross Profit Margin
56.01%
57.04%
51.74%
38.2%
46.44%
-8.22%
48.83%
PAT Margin
41.53%
42.31%
37.56%
28.23%
34.71%
-7.21%
36.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 23.63% vs 20.20% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 21.35% vs 35.40% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 16.74% vs 19.14% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -27.66% vs 83.02% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of United Therapeutics Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,877.40
2,355.30
522.10
22.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,877.40
2,355.30
522.10
22.17%
Raw Material Cost
309.70
57.50
252.20
438.61%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
42.90
126.60
-83.70
-66.11%
Selling and Distribution Expenses
709.70
993.20
-283.50
-28.54%
Other Expenses
43.81
58.10
-14.29
-24.60%
Total Expenditure (Excl Depreciation)
1,500.40
1,758.30
-257.90
-14.67%
Operating Profit (PBDIT) excl Other Income
1,377.00
597.00
780.00
130.65%
Other Income
204.90
91.00
113.90
125.16%
Operating Profit (PBDIT)
1,654.40
715.10
939.30
131.35%
Interest
42.90
126.60
-83.70
-66.11%
Exceptional Items
0.00
-75.40
75.40
100.00%
Gross Profit (PBDT)
2,567.70
2,297.80
269.90
11.75%
Depreciation
72.50
27.10
45.40
167.53%
Profit Before Tax
1,539.00
486.00
1,053.00
216.67%
Tax
343.90
144.70
199.20
137.66%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,195.10
341.30
853.80
250.16%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,195.10
341.30
853.80
250.16%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,195.10
341.30
853.80
250.16%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
6,444.00
2,589.70
3,854.30
148.83%
Earnings per share (EPS)
24.64
3.29
21.35
648.94%
Diluted Earnings per share
24.64
3.29
21.35
648.94%
Operating Profit Margin (Excl OI)
47.86%
25.35%
0.00
22.51%
Gross Profit Margin
56.01%
21.78%
0.00
34.23%
PAT Margin
41.53%
14.49%
0.00
27.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 287.74 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 23.63% vs 20.20% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 119.51 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.35% vs 35.40% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 144.95 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.74% vs 19.14% in Dec 2023

Annual - Interest
Interest 4.29 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -27.66% vs 83.02% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 47.86%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."